idarubicin hydrochloride

Idarubicin An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.

Molecular Formula: C₂₆H₂₈ClNO₉

InChI: InChI=1/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10-,15-,16-,17-,21+,26-;/m0./s1

InChIKey: InChIKey=JVHPTYWUBOQMBP-RVFAQHLVBA
SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl

Names:
    D01747
    Idamycin (TN)
    Idamycin
    Idarubicin hydrochloride (JP15/USP)
    idarubicin hydrochloride
    (7S,9R)-9-acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
    57852-57-0

Registries:
    PubChem CID 636362
    PubChem ID 7848810